Home/Filings/4/0001127602-25-012384
4//SEC Filing

WHEELER CRAIG A 4

Accession 0001127602-25-012384

CIK 0001492422other

Filed

Apr 20, 8:00 PM ET

Accepted

Apr 21, 4:23 PM ET

Size

6.8 KB

Accession

0001127602-25-012384

Insider Transaction Report

Form 4
Period: 2025-04-17
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-04-17$18.20/sh+28,195$513,14928,195 total
    Exercise: $18.20Exp: 2032-04-17Common Stock (28,195 underlying)
  • Award

    Common Stock

    2025-04-17+16,48316,483 total
Footnotes (2)
  • [F1]This restricted stock unit was granted on April 17, 2025. The restricted stock unit will fully vest on the first anniversary of the date of grant, subject to his continued service as a director, or upon later termination of his service as adirector at his election.
  • [F2]This represents a stock option award granted April 17, 2025 that vest 1/3rd per year over a three-year period subject to continued service.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001229450

Filing Metadata

Form type
4
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:23 PM ET
Size
6.8 KB